ARTICLE
|
doi:10.20944/preprints202404.1612.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
TNBC; BAY1816032; BUB1; PARP; olaparib; cisplatin; paclitaxel; radiation; chemoradiation
Online: 24 April 2024 (11:35:50 CEST)